Esperion Therapeutics CEO Sheldon Koenig's 2023 pay falls 22% to $3M
Esperion Therapeutics reports 2023 executive compensation
By ExecPay News
Published: April 11, 2024
Esperion Therapeutics reported fiscal year 2023 executive compensation information on April 11, 2024.
In 2023, three executives at Esperion Therapeutics received on average a compensation package of $1.8M, a 17% decrease compared to previous year.
Average pay of disclosed executives at Esperion Therapeutics
Sheldon L. Koenig, Chief Executive Officer, received $3M in total, which decreased by 22% compared to 2022. 43% of Koenig's compensation, or $1.3M, was in option awards. Koenig also received $542K in non-equity incentive plan, $721K in salary, $422K in stock awards, as well as $16K in other compensation.
JoAnne Foody, Chief Medical Officer, received a compensation package of $1.4M, which decreased by 7% compared to previous year. 37% of the compensation package, or $528K, was in salary.
Eric Warren, Chief Commercial Officer, earned $1.1M in 2023.
Related executives
You may also like
Source: SEC filing on April 11, 2024.